WallStreetZenWallStreetZen

NASDAQ: LEXX
Lexaria Bioscience Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for LEXX

Based on 1 analyst offering 12 month price targets for Lexaria Bioscience Corp.
Min Forecast
$12.00+433.33%
Avg Forecast
$12.00+433.33%
Max Forecast
$12.00+433.33%

Should I buy or sell LEXX stock?

Based on 1 analyst offering ratings for Lexaria Bioscience Corp.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their LEXX stock forecasts and price targets.

LEXX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-05

1 of 1

Forecast return on equity

Is LEXX forecast to generate an efficient return?
Company
N/A
Industry
8.97%
Market
29.52%

Forecast return on assets

Is LEXX forecast to generate an efficient return on assets?
Company
N/A
Industry
9.71%

LEXX revenue forecast

What is LEXX's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$810.0k+109.85%
Avg 2 year Forecast
$980.0k+153.89%
LEXX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

LEXX revenue growth forecast

How is LEXX forecast to perform vs Biotechnology companies and vs the US market?
Company
109.85%
Industry
252.28%
Market
13.58%
LEXX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
LEXX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

LEXX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
LEXX$2.25$12.00+433.33%Strong Buy
LPCN$5.44N/AN/A
NRXP$3.02N/AN/A
ACST$3.07$6.00+95.44%Buy
SPRB$0.70$5.40+670.33%Buy
View Top Biotech Stocks

Lexaria Bioscience Stock Forecast FAQ

Is Lexaria Bioscience Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: LEXX) stock is to Strong Buy LEXX stock.

Out of 1 analyst, 1 (100%) are recommending LEXX as a Strong Buy, 0 (0%) are recommending LEXX as a Buy, 0 (0%) are recommending LEXX as a Hold, 0 (0%) are recommending LEXX as a Sell, and 0 (0%) are recommending LEXX as a Strong Sell.

If you're new to stock investing, here's how to buy Lexaria Bioscience stock.

What is LEXX's revenue growth forecast for 2024-2025?

(NASDAQ: LEXX) Lexaria Bioscience's forecast annual revenue growth rate of 109.85% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 252.28%, and while it is forecast to beat the US market's average forecast revenue growth rate of 13.58%.

Lexaria Bioscience's revenue in 2024 is $385,995.On average, 1 Wall Street analysts forecast LEXX's revenue for 2024 to be $10,437,395, with the lowest LEXX revenue forecast at $10,437,395, and the highest LEXX revenue forecast at $10,437,395.

In 2025, LEXX is forecast to generate $12,627,960 in revenue, with the lowest revenue forecast at $12,627,960 and the highest revenue forecast at $12,627,960.

What is LEXX's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: LEXX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 9.71%.

What is LEXX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year LEXX price target, the average LEXX price target is $12.00, with the highest LEXX stock price forecast at $12.00 and the lowest LEXX stock price forecast at $12.00.

The Wall Street analyst predicted that Lexaria Bioscience's share price could reach $12.00 by Mar 5, 2025. The average Lexaria Bioscience stock price prediction forecasts a potential upside of 433.33% from the current LEXX share price of $2.25.

What is LEXX's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: LEXX) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.